Target intelligence / Profile preview

Desmin (DES)

Target
DES
Molecular classification
Intermediate filament protein, type III intermediate filament
01

Overview

Desmin is a muscle-specific, type III intermediate filament protein essential for the structural integrity and function of muscle tissue[1][5][7]. It is encoded by the DES gene and found predominantly in cardiac, skeletal, and smooth muscle cells[1][3][5][7]. Desmin connects the sarcolemma, Z disk, and nuclear envelope, providing a scaffold that links the contractile apparatus to the cell’s nucleus, mitochondria, and other organelles, enabling efficient force transmission and mechanical stability during muscle contraction[1][3][6]. Mutations in the DES gene can cause a range of myopathies and cardiomyopathies, collectively termed “desminopathies”[2][5]. Desmin is not considered a direct therapeutic target (receptor, enzyme, etc.); rather, it serves as a critical structural protein and a diagnostic biomarker in muscle pathology[1][3][5].

Other names
DES proteinDesmin intermediate filament
02

Mechanism of action

Not a direct drug target; pathologies are due to mutations or abnormal assembly rather than targeted pharmacologic modulation.

03

Biological functions

Maintenance of muscle architectureStructural integrity of muscle fibersSarcomere organizationForce transmission in muscle cellsMitochondrial organization
04

Disease associations

CardiomyopathyMyopathy (including myofibrillar myopathy)Cardiac conduction defectsArrhythmias
05

Biomarkers

Desmin protein is used as a diagnostic marker for muscle tissue identification in pathology“desmin positivity” is a biomarker for muscle tumors and myopathies

Beyond the preview

Go deeper on Desmin (DES).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Desmin (DES).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call